24 related articles for article (PubMed ID: 8742919)
1. Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C.
Larrea E; Garcia N; Qian C; Civeira MP; Prieto J
Hepatology; 1996 Feb; 23(2):210-7. PubMed ID: 8591843
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors for beneficial response to interferon-alfa therapy in chronic hepatitis C.
Yoon SK; Kim SS; Park YM; Shim KS; Lee CD; Sun HS; Park DH; Kim BS; Ryu WS; Cho JM
Korean J Intern Med; 1995 Jul; 10(2):94-102. PubMed ID: 7495780
[TBL] [Abstract][Full Text] [Related]
3. Transgenic mouse expressing a full-length hepatitis C virus cDNA.
Matsuda J; Suzuki M; Nozaki C; Shinya N; Tashiro K; Mizuno K; Uchinuno Y; Yamamura K
Jpn J Cancer Res; 1998 Feb; 89(2):150-8. PubMed ID: 9548442
[TBL] [Abstract][Full Text] [Related]
4. Lipid peroxidation products and antioxidants in human disease.
Romero FJ; Bosch-Morell F; Romero MJ; Jareño EJ; Romero B; Marín N; Romá J
Environ Health Perspect; 1998 Oct; 106 Suppl 5(Suppl 5):1229-34. PubMed ID: 9788902
[TBL] [Abstract][Full Text] [Related]
5. Therapy of hepatitis C: patients with normal aminotransferase levels.
Marcellin P; Lévy S; Erlinger S
Hepatology; 1997 Sep; 26(3 Suppl 1):133S-136S. PubMed ID: 9305678
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of efficacy of antiviral therapy for chronic hepatitis C: a EUROHEP Consensus Report on response criteria.
Craxì A; Almasio P; Schalm S
J Viral Hepat; 1996 Sep; 3(5):273-6. PubMed ID: 8914009
[No Abstract] [Full Text] [Related]
7. Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy.
Shindo M; Arai K; Sokawa Y; Okuno T
Ann Intern Med; 1995 Apr; 122(8):586-91. PubMed ID: 7887552
[TBL] [Abstract][Full Text] [Related]
8. Prediction of relapses after interferon-alpha therapy by hepatitis C virus RNA in peripheral blood mononuclear cells.
Kusaka S; Okusa T; Araki A; Fujiki K; Takashimizu I; Okayasu I; Yamamoto N; Sato C
J Med Virol; 1995 Jul; 46(3):265-8. PubMed ID: 7561801
[TBL] [Abstract][Full Text] [Related]
9. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
Marcellin P; Boyer N; Gervais A; Martinot M; Pouteau M; Castelnau C; Kilani A; Areias J; Auperin A; Benhamou JP; Degott C; Erlinger S
Ann Intern Med; 1997 Nov; 127(10):875-81. PubMed ID: 9382365
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon alpha 2a therapy.
Suzuki T; Tanaka E; Matsumoto A; Urushihara A; Sodeyama T
J Med Virol; 1995 Jun; 46(2):162-8. PubMed ID: 7636506
[TBL] [Abstract][Full Text] [Related]
11. Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence.
Bizollon T; Ahmed SN; Radenne S; Chevallier M; Chevallier P; Parvaz P; Guichard S; Ducerf C; Baulieux J; Zoulim F; Trepo C
Gut; 2003 Feb; 52(2):283-7. PubMed ID: 12524414
[TBL] [Abstract][Full Text] [Related]
12. Hepatic HCV-RNA as a predictor of outcome after interferon therapy in patients with chronic hepatitis C.
Kondo M; Tanaka K; Ikeda M; Arata S; Saito S; Sakaguchi T; Morimoto M; Fujii T; Mitsui K; Okazaki H; Hoshino M; Sekihara H
J Gastroenterol Hepatol; 1996 Mar; 11(3):236-40. PubMed ID: 8742919
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
